These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 33539286)

  • 1. Relationship between allergic sensitisation-associated single-nucleotide polymorphisms and allergic transfusion reactions and febrile non-haemolytic transfusion reactions in paediatric cases.
    Ide Y; Yanagisawa R; Kobayashi J; Komori K; Matsuda K; Amano Y; Nakazawa Y; Takeshita T; Sakashita K; Tozuka M
    Blood Transfus; 2022 Mar; 20(2):94-102. PubMed ID: 33539286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Basophil activation test for allergic and febrile non-haemolytic transfusion reactions among paediatric patients with haematological or oncological disease.
    Usami Y; Yanagisawa R; Kanai R; Ide Y; Konno S; Iwama M; Futatsugi A; Takeshita T; Furui Y; Komori K; Kurata T; Saito S; Tanaka M; Nakazawa Y; Sakashita K; Tozuka M
    Vox Sang; 2023 Jan; 118(1):41-48. PubMed ID: 36224113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of Clinical Factors Associated with the Occurrence Time of AllergicTransfusion Reactions or Febrile Non-HemolyticTransfusion Reactions.
    Yanagisawa R; Yamanaka R; Shimodaira S
    Ann Clin Lab Sci; 2022 May; 52(3):382-390. PubMed ID: 35777807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of clinical presentations of allergic transfusion reactions and febrile non-haemolytic transfusion reactions in paediatric patients.
    Yanagisawa R; Tatsuzawa Y; Ono T; Kobayashi J; Tokutake Y; Hidaka E; Sakashita K; Nakamura T
    Vox Sang; 2019 Nov; 114(8):826-834. PubMed ID: 31463954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors related to allergic transfusion reactions and febrile non-haemolytic transfusion reactions in children.
    Yanagisawa R; Shimodaira S; Sakashita K; Hidaka Y; Kojima S; Nishijima F; Hidaka E; Shiohara M; Nakamura T
    Vox Sang; 2016 May; 110(4):376-84. PubMed ID: 26808840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Febrile non-haemolytic transfusion reaction occurrence and potential risk factors among the U.S. elderly transfused in the inpatient setting, as recorded in Medicare databases during 2011-2012.
    Menis M; Forshee RA; Anderson SA; McKean S; Gondalia R; Warnock R; Johnson C; Mintz PD; Worrall CM; Kelman JA; Izurieta HS
    Vox Sang; 2015 Apr; 108(3):251-61. PubMed ID: 25470076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in circulating inflammatory markers following febrile non-haemolytic transfusion reactions to leucoreduced red cells.
    Larsen R; Sandhu N; Heegaard NHH; Ullum H; von Stemann JH; Sørensen E; Nellemann DS; Hansen MB
    Vox Sang; 2018 Jan; 113(1):76-79. PubMed ID: 29023768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of febrile but not allergic reactions to RBCs and platelets after conversion to universal prestorage leukoreduction.
    Paglino JC; Pomper GJ; Fisch GS; Champion MH; Snyder EL
    Transfusion; 2004 Jan; 44(1):16-24. PubMed ID: 14692962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preventing adverse reactions in pediatric transfusions using washed platelet concentrate.
    Yanagisawa R
    Pediatr Int; 2021 Apr; 63(4):391-403. PubMed ID: 33290634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrospective evaluation of acute transfusion reactions in a tertiary hospital in Erzurum, Turkey.
    Kar YD; Yildirgan DO; Aygun B; Erdogmus D; Altinkaynak K
    North Clin Istanb; 2021; 8(3):261-268. PubMed ID: 34222807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human platelet antigens are associated with febrile non-hemolytic transfusion reactions.
    Chen DP; Wen YH; Lu JJ; Tseng CP; Chen WL; Chang SW
    Clin Chim Acta; 2017 Nov; 474():120-123. PubMed ID: 28919492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prestorage universal WBC reduction of RBC units does not affect the incidence of transfusion reactions.
    Uhlmann EJ; Isgriggs E; Wallhermfechtel M; Goodnough LT
    Transfusion; 2001 Aug; 41(8):997-1000. PubMed ID: 11493730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A retrospective observational study to assess adverse transfusion reactions of patients with and without prior transfusion history.
    Kato H; Nakayama T; Uruma M; Okuyama Y; Handa M; Tomiyama Y; Shimodaira S; Takamoto S
    Vox Sang; 2015 Apr; 108(3):243-50. PubMed ID: 25536173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Major histocompatibility complex (MHC) antigens polymorphism and alloimmunization study in thalassemia patients with febrile non-hemolytic transfusion reaction (FNHTR).
    Dadashi M; Ostadali M; Mohammadi S; Azarkeivan A; Zadsar M
    Transfus Clin Biol; 2023 May; 30(2):205-211. PubMed ID: 36328308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Research progress on febrile non-hemolytic transfusion reaction: a narrative review.
    Wang H; Ren D; Sun H; Liu J
    Ann Transl Med; 2022 Dec; 10(24):1401. PubMed ID: 36660666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and Analysis of 7 Years Adverse Transfusion Reaction: A Retrospective Analysis.
    Saha S; Krishna D; Prasath R; Sachan D
    Indian J Hematol Blood Transfus; 2020 Jan; 36(1):149-155. PubMed ID: 32158098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-storage leucocyte depletion and transfusion reaction rates in cancer patients.
    Da Ponte A; Bidoli E; Talamini R; Steffan A; Abbruzzese L; Toffola RT; De Marco L
    Transfus Med; 2005 Feb; 15(1):37-43. PubMed ID: 15713127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissecting the complexity of pediatric blood transfusions and risk of adverse reactions in Aotearoa New Zealand.
    Wei WH; Cho G; Smith M; Morley S
    Blood Transfus; 2023 Sep; 21(5):428-436. PubMed ID: 36580030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of leucoreduction for prevention of febrile non-haemolytic transfusion reactions.
    Tsantes AE; Kyriakou E; Nikolopoulos GK; Stylos D; Sidhom M; Bonovas S; Douramani P; Kalantzis D; Kokoris S; Valsami S; Stamoulis K; Politou M; Foudoulaki-Paparizos L
    Blood Transfus; 2014 Apr; 12(2):232-7. PubMed ID: 24931843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The utility of < or =3-day-old whole-blood platelets in reducing the incidence of febrile nonhemolytic transfusion reactions.
    Kelley DL; Mangini J; Lopez-Plaza I; Triulzi DJ
    Transfusion; 2000 Apr; 40(4):439-42. PubMed ID: 10773056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.